Novel Labs Inc Company Profile
What is the competitive landscape for NOVEL LABS INC
NOVEL LABS INC has fifty-six approved drugs.
There are three tentative approvals on NOVEL LABS INC drugs.
Summary for Novel Labs Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 41 |
| NDAs: | 56 |
Drugs and US Patents for Novel Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | MISOPROSTOL | misoprostol | TABLET;ORAL | 091667-002 | Jul 25, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Novel Labs Inc | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 209786-001 | Aug 29, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novel Labs Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 206245-001 | Dec 1, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Novel Labs Inc | AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 202829-003 | Mar 30, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
